Aeglea Competitors and Similar CompaniesClear all
PHAXIAM Therapeutics's competitors and similar companies include Aptevo Therapeutics.
 PHAXIAM Therapeutics PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors. |  Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. | |
Founding Date | Founding Date 2004 | Founding Date 2016 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Lyon, FR HQ Cambridge, US Princeton, US | Locations Seattle, US HQ |
Employees | Employees 49 | Employees 1182% decrease |
Valuation ($) | Valuation ($) 52.8 m | Valuation ($) 4.1 m |
Financial | ||
Net income | Net income (€23.5m) (FY, 2023) | Net income ($26m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Aptevo Therapeutics
HQ
Seattle, US
Employees
118↓ 2% decrease
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
View company